Salmeterol in the management of paediatric asthma.

Suppr

超能文献

作者信息

Jones K

出版信息

Respir Med. 1994 Oct;88(9):639-43. doi: 10.1016/s0954-6111(05)80059-9.

DOI:10.1016/s0954-6111(05)80059-9

PMID:7809435

Abstract

摘要

相似文献

Salmeterol in the management of paediatric asthma.

Respir Med. 1994 Oct;88(9):639-43. doi: 10.1016/s0954-6111(05)80059-9.

Practical pharmacotherapy for pediatric asthma.儿童哮喘的实用药物治疗

Pediatr Ann. 2000 Dec;29(12):768-73. doi: 10.3928/0090-4481-20001201-11.

Salmeterol: its place in asthma management.

Ann Pharmacother. 1994 Sep;28(9):1100-2. doi: 10.1177/106002809402800916.

Asthma group issues guidelines for safe use of salmeterol.

Am J Health Syst Pharm. 1996 Dec 15;53(24):2943-4. doi: 10.1093/ajhp/53.24.2943.

Oral montelukast versus inhaled salmeterol to prevent exercise-induced bonchonconstriction.

Ann Intern Med. 2000 Sep 5;133(5):392; author reply 392-3. doi: 10.7326/0003-4819-133-5-200009050-00020.

Salmeterol: a novel, long-acting beta 2-agonist.沙美特罗：一种新型长效β2受体激动剂。

Ann Pharmacother. 1993 Dec;27(12):1478-87. doi: 10.1177/106002809302701214.

Salmeterol xinafoate in asthma.

JAMA. 1994;272(20):1575-6. doi: 10.1001/jama.272.20.1575a.

Oral montelukast versus inhaled salmeterol to prevent exercise-induced bronchoconstriction.

Ann Intern Med. 2000 Sep 5;133(5):392; author reply 392-3. doi: 10.7326/0003-4819-133-5-200009050-00019.

Life-threatening asthma during treatment with salmeterol.沙美特罗治疗期间的危及生命的哮喘。

N Engl J Med. 2006 Aug 24;355(8):852-3. doi: 10.1056/NEJMc066282.

The Salmeterol Multicenter Asthma Research Trial.

Chest. 2006 Sep;130(3):928; author reply 928-9. doi: 10.1378/chest.130.3.928.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Salmeterol in the management of paediatric asthma.

Respir Med. 1994 Oct;88(9):639-43. doi: 10.1016/s0954-6111(05)80059-9.

Practical pharmacotherapy for pediatric asthma.儿童哮喘的实用药物治疗

Pediatr Ann. 2000 Dec;29(12):768-73. doi: 10.3928/0090-4481-20001201-11.

Salmeterol: its place in asthma management.

Ann Pharmacother. 1994 Sep;28(9):1100-2. doi: 10.1177/106002809402800916.

Asthma group issues guidelines for safe use of salmeterol.

Am J Health Syst Pharm. 1996 Dec 15;53(24):2943-4. doi: 10.1093/ajhp/53.24.2943.

Oral montelukast versus inhaled salmeterol to prevent exercise-induced bonchonconstriction.

Ann Intern Med. 2000 Sep 5;133(5):392; author reply 392-3. doi: 10.7326/0003-4819-133-5-200009050-00020.

Salmeterol: a novel, long-acting beta 2-agonist.沙美特罗：一种新型长效β2受体激动剂。

Ann Pharmacother. 1993 Dec;27(12):1478-87. doi: 10.1177/106002809302701214.

Salmeterol xinafoate in asthma.

JAMA. 1994;272(20):1575-6. doi: 10.1001/jama.272.20.1575a.

Oral montelukast versus inhaled salmeterol to prevent exercise-induced bronchoconstriction.

Ann Intern Med. 2000 Sep 5;133(5):392; author reply 392-3. doi: 10.7326/0003-4819-133-5-200009050-00019.

Life-threatening asthma during treatment with salmeterol.沙美特罗治疗期间的危及生命的哮喘。

N Engl J Med. 2006 Aug 24;355(8):852-3. doi: 10.1056/NEJMc066282.

The Salmeterol Multicenter Asthma Research Trial.

Chest. 2006 Sep;130(3):928; author reply 928-9. doi: 10.1378/chest.130.3.928.